“… Considerable efforts have been devoted to the development of synthetic routes yielding this privileged drug scaffold, which have traditionally focused on the reduction of diketopiperazines, the reductive amination of dicarbonyl compounds, and transition-metal-catalyzed cyclization reactions . These methods often require multistep synthesis, as well as protecting and deprotecting steps . More sustainable approaches include a “borrowing hydrogen” method, which uses 1,5-diols and primary amines, the synthesis of 2-substituted piperazines by an iridium photocatalyst, and biocatalytic reductive aminations of 1,2-dicarbonyl and 1,2-diamine substrates, which yield piperazines in an atom-economical fashion …”